Home/Filings/4/0000899243-21-039303
4//SEC Filing

Ros Matthew 4

Accession 0000899243-21-039303

CIK 0001622229other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 7:11 PM ET

Size

5.9 KB

Accession

0000899243-21-039303

Insider Transaction Report

Form 4
Period: 2021-10-01
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-10-01$5.03/sh+2,463$12,3932,463 total
    Exercise: $8.54Exp: 2031-10-01Common Stock (2,463 underlying)
Footnotes (2)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
  • [F2]This option is fully vested at time of grant.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001673802

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 7:11 PM ET
Size
5.9 KB